Sean Robinson, MD
Sports Medicine · Folsom, CANPI 1114346111
Payments from drug & device makers
What this record shows
This record is dominated by education: $41,285 of the $65,995 with a category attached, or 62.6%. 13 manufacturers reported payments, led by Micromed Inc at 45.0% of the total. Reporting peaked in 2019 at $33,791 and has fallen 94.1% since, to $2,002 in 2025. Among sports medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $507.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Micromed Inc$30K
- Arthrex$26K
- Stryker$5K
- Smith+Nephew$2K
- Evolution Surgical, Inc$2K
- Sequoia Surgical, Inc.$849
- plus $615 from 7 others
What the payments were for
- Grants$20,00030%
- Travel & lodging$3551%
- Food & beverage$4,3557%
- Education$41,28563%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Micromed Inc | 25 | $29,713 |
| Arthrex | 10 | $25,937 |
| Stryker | 74 | $4,641 |
| Smith+Nephew | 4 | $2,382 |
| Evolution Surgical, Inc | 1 | $1,857 |
| Sequoia Surgical, Inc. | 2 | $849 |
| Johnson & Johnson(2 entities) | 5 | $333 |
| Team_makena_llc | 1 | $109 |
| Vericel Corporation | 3 | $60 |
| Avanos Medical | 2 | $46 |
| Anika Therapeutics, Inc. | 1 | $24 |
| Bioventus LLC | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$65,995 in reported general payments places this provider in the 90th percentile of 662 sports medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 149 | $1,629 |
| Ibuprofen | 232 | $1,628 |
| Famotidine | 113 | $773 |
| Diclofenac Sodium | 31 | $432 |
| Ondansetron OdtOndansetron | 101 | $373 |
| Meloxicam | 69 | $337 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $278 |
| Tramadol Hcl | 15 | $125 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Folsom
- Neal ElattracheLos Angeles$51M
- Nathaniel CohenLos Gatos$6.4M
- Thomas KnappSanta Monica$2.5M
- Michael FreehillStanford$1.6M
- Allan MishraMenlo Park$1.5M
- Heinz Hoeneckela Jolla$1.4M
- Seth ShermanStanford$1.1M
- Stephan YacoubianBurbank$1M
- Stephen Snydervan Nuys$922K
- Deryk JonesSan Carlos$915K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.